The JAK-STAT signaling pathway plays a pivotal role not only in immune and inflammatory regulation, but is also closely associated with a variety of metabolic disorders, including obesity, insulin resistance, non-alcoholic fatty liver disease, and atherosclerosis [42,43]. The gene discussed is SOAT1; the disease is metabolic dysfunction-associated steatotic liver disease.